|
⚲
|
| Keyboard |
| Thomas Brian C
✚
|
|
|---|---|
| CIK # | 0001996097 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001996097] | |
| 4 | [0001996097] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Metagenomi Therapeutics Inc | |
| Thomas Brian C |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2025-12-05 | Sell | 3,830 | $1.77 | 6,779 |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2025-09-05 | Sell | 2,701 | $1.81 | 4,889 |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2025-06-06 | Sell | 10,785 | $1.75 | 18,874 |
|
Metagenomi Therapeutics Inc MGX
Stock Option (Right to Buy) · derivative
|
2025-04-01 | Grant | 196,000 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2025-04-01 | Grant | 32,000 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2024-04-01 | Grant | 118,992 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Stock Option (Right to Buy) · derivative
|
2024-04-01 | Grant | 500,323 | $0.00 |